Florida Region

1-888-TENET4U

5810 Coral Ridge Drive, Suite 300 Coral Springs, Florida 33076

Neuroscience Clinical Trials

NEUROSCIENCE CLINICAL TRIALS

PROSPER

  • The overall goal of PROSPER is to create a national, sustainable model to improve decision-making and patient-centered stroke outcomes through comparative effectiveness research.
  • The Principal Investigator is Dr. Nils Mueller-Kronast.
  • The Clinical Coordinator is Marianne Torres-Malaga.
  • The Sponsor is Duke Clinical Research Institute.
  • The Study will take place at Delray Medical Center.
  • Currently Closed to Enrollment.

TREVO

  • To assess real world performance of the Trevo® Retriever which is intended to restore blood flow in the neurovasculature by removing thrombus in subjects experiencing ischemic stroke.
  • The Principal Investigators are Dr. Nils Mueller-Kronast, Dr. Ali Malek & Dr. Ritesh Kaushal.
  • The Clinical Coordinators are Marianne Torres-Malaga, Andres Alvarez-Pinzon & Rafael Perez.
  • The Sponsor is Stryker Neurovascular.
  • The Study will take place at Delray Medical Center, St. Mary's Medical Center & Palmetto General Hospital.
  • Click here to for more information

SOCRATES

  • SOCRATES –Acute Stroke Or Transient IsChaemic Attack TReated with Aspirin or Ticagrelor and Patient OutcomES. A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events with Ticagrelor Compared to Aspirin (ASA) in Patients with Acute Ischaemic Stroke or TIA.
  • The Principal Investigators are Dr. Ali Malek & Dr. Arun Talkad.
  • The Clinical Coordinator is Andres Alvarez-Pinzon.
  • The Sponsor is AstraZeneca.
  • The Study will take place at St. Mary's Medical Center & Palm Beach Gardens Medical Center.
  • Currently Closed to Enrollment.

RESPECT-ESUS

  • Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate (110 mg or 150 mg, oral b.i.d.) versus acetylsalicylic acid (100 mg oral q.d.) in patients with Embolic Stroke of Undetermined Source (RESPECT ESUS).
  • The Principal Investigators are Dr. Nils Mueller-Kronast, Dr. Ali Malek & Dr. Ritesh Kaushal.
  • The Clinical Coordinators are Marianne Torres-Malaga, Helen Francis, Andres Alvarez-Pinzon & Rafael Perez.
  • The Sponsor is Boehringer Ingelheim.
  • The Study will take place at Delray Medical Center, St. Mary's Medical Center & Palmetto General Hopsital.
  • Click here for more information

STING - ICT107

  • STING (Sudy of Immunotherapy in Newly Diagnosed Glioblastoma): A Phase III randomized double-blind, controlled study of ICT-107 with maintenance temozolomide (TMZ) in newly diagnosed glioblastoma following resection and concomitant TMZ chemoradiotherapy.
  • The Principal Investigator is Dr. Lloyd Zucker.
  • The Clinical Coordinator is Jenny Zucker.
  • The Sponsor is ImmunoCellular Therapeutics Ltd.
  • The Study will take place at Delray Medical Center.
  • Click here for more information 

Stay Connected

Join us on Facebook

Watch us on YouTube

Follow us on Twitter